Theseus Pharmaceuticals, Inc. THRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Theseus Pharmaceuticals, Inc. (THRX), 포함 39 건 매수 및 8 건 매도. 내부자 매수 총액은 $29.44M 내부자 매도 총액은 $4.71M.

최근 활동이 있는 주요 내부자에는 Orbimed Advisors Llc, Hayden Donald J Jr, Gordon Carl L. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — THRX

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2024-02-14	Orbimed Advisors Llc	10 Percent Owner	공개매수 (매도)	650,600	$4.05	$2.63M	-
2024-02-14	Hayden Donald J Jr	Director	주식 반환	3,250	-	-	-
2024-02-14	Gordon Carl L	10 Percent Owner	주식 반환	3,250	-	-	-
2024-02-14	Stein Steven H	Director	주식 반환	3,250	-	-	-
2024-02-14	Dukes Iain D.	Director	주식 반환	61,549	$4.03	$248.33K	-
2024-02-14	Yi Kathy	Director	주식 반환	99,634	$4.03	$401.99K	-
2024-02-14	Dahms Bradford D.	President and CFO	주식 반환	332,114	$4.03	$1.34M	-
2023-11-06	Shakespeare William	See Remarks	옵션 행사 (매도)	251,084	$0.32	$80.35K	93,260
2023-07-17	Orbimed Advisors Llc	10 Percent Owner	정보 매수	151,450	$3.05	$461.92K	650,600
2023-07-17	Gordon Carl L	10 Percent Owner	정보 매수	151,450	$3.05	$461.92K	650,600
2023-07-17	Foresite Capital Management V, Llc	10 Percent Owner	정보 매수	176,550	$2.97	$524.35K	1,385,825
2023-06-13	Hayden Donald J Jr	Director	RSU 부여	3,250	-	-	3,250
2023-06-13	Gordon Carl L	10 Percent Owner	RSU 부여	3,250	-	-	3,250
2023-06-13	Stein Steven H	Director	RSU 부여	3,250	-	-	3,250
2023-06-13	Dukes Iain D.	Director	RSU 부여	3,250	-	-	3,250
2023-06-13	Yi Kathy	Director	RSU 부여	3,250	-	-	3,250
2023-03-01	Clackson Timothy P	President and CEO	RSU 부여	45,625	-	-	45,625
2023-03-01	Dahms Bradford D.	Chief Financial Officer	RSU 부여	17,500	-	-	17,500
2023-03-01	Kerstein David	Chief Medical Officer	RSU 부여	17,500	-	-	17,500
2023-03-01	Rivera Victor	Chief Scientific Officer	RSU 부여	16,250	-	-	16,250
2023-03-01	Shakespeare William	See Remarks	RSU 부여	21,250	-	-	21,250
2023-02-17	Clackson Timothy P	President and CEO	RSU 부여	273,750	$11.42	$3.13M	273,750
2023-02-17	Dahms Bradford D.	Chief Financial Officer	RSU 부여	105,000	$11.42	$1.2M	105,000
2023-02-17	Kerstein David	Chief Medical Officer	RSU 부여	105,000	$11.42	$1.2M	105,000
2023-02-17	Rivera Victor	Chief Scientific Officer	RSU 부여	97,500	$11.42	$1.11M	97,500
2023-02-17	Shakespeare William	See Remarks	RSU 부여	127,500	$11.42	$1.46M	127,500
2022-12-30	Hayden Donald J Jr	Director	정보 매수	9,900	$5.00	$49.49K	10,000
2022-12-29	Hayden Donald J Jr	Director	정보 매수	100	$5.00	$500.00	100
2022-12-29	Foresite Capital Management V, Llc	Director	정보 매수	250,000	$5.00	$1.25M	1,209,275
2022-11-30	Dahms Bradford D.	Chief Financial Officer	정보 매수	1,502	$6.66	$10K	6,142
2022-11-11	Clackson Timothy P	President and CEO	정보 매수	2,500	$6.80	$17K	351,030
2022-11-07	Orbimed Advisors Llc	Director	정보 매수	192,000	$5.21	$1M	16,734,518
2022-11-07	Gordon Carl L	Director	정보 매수	192,000	$5.21	$1M	16,734,518
2022-10-17	Stein Steven H	Director	알 수 없음	-	-	-	-
2022-10-17	Stein Steven H	Director	RSU 부여	60,000	-	-	60,000
2022-06-10	Gordon Carl L	10 Percent Owner	RSU 부여	30,000	$5.75	$172.5K	30,000
2022-06-10	Dukes Iain D.	Chairman	RSU 부여	15,000	-	-	15,000
2022-06-10	Yi Kathy	Director	RSU 부여	30,000	-	-	30,000
2022-06-09	Foresite Capital Management V, Llc	Director	알 수 없음	-	-	-	959,275
2022-05-17	Hayden Donald J Jr	Director	알 수 없음	-	-	-	-
2022-05-17	Hayden Donald J Jr	Director	RSU 부여	60,000	$8.02	$481.2K	60,000
2022-02-18	Clackson Timothy P	President and CEO	RSU 부여	450,000	$11.21	$5.04M	450,000
2022-02-18	Dahms Bradford D.	Chief Financial Officer	RSU 부여	150,000	$11.21	$1.68M	150,000
2022-02-18	Kerstein David	Chief Medical Officer	RSU 부여	150,000	$11.21	$1.68M	150,000
2022-02-18	Dalgarno David	Chief Technical Officer	RSU 부여	130,000	$11.21	$1.46M	130,000
2022-02-18	Rivera Victor	Chief Scientific Officer	RSU 부여	130,000	$11.21	$1.46M	130,000
2022-02-18	Shakespeare William	See Remarks	RSU 부여	180,000	$11.21	$2.02M	180,000
2022-01-21	Orbimed Advisors Llc	10 Percent Owner	정보 매수	111,896	$9.97	$1.12M	16,542,652
2022-01-21	Gordon Carl L	10 Percent Owner	정보 매수	111,896	$9.97	$1.12M	16,542,652
2022-01-20	Orbimed Advisors Llc	10 Percent Owner	정보 매수	35,000	$9.95	$348.25K	16,430,756